Top Markets
Coin of the day
Merck & Co., Inc. Merck & Co., Inc.

Merck & Co., Inc.

MRK
Classifica tra le azioni #40
Merck & Co., Inc. is a global healthcare leader with operations spanning two... Merck & Co., Inc. is a global healthcare leader with operations spanning two core divisions: Pharmaceuticals and Animal Health. The Pharmaceutical segment is dedicated to human health, offering a broad spectrum of medicinal products. These cover crucial therapeutic areas such as oncology, acute hospital care, immunology, neuroscience, virology, cardiovascular conditions, and diabetes. This division also develops vital preventive vaccines for pediatric, adolescent, and adult populations. Meanwhile, the Animal Health segment focuses on the research, development, manufacturing, and marketing of veterinary medications, vaccines, and comprehensive health management solutions for animals. This division further provides innovative digital products designed for animal identification, traceability, and continuous monitoring. Merck's extensive clientele encompasses drug wholesalers, pharmacies, hospitals, and government agencies. It also serves managed healthcare organizations, including health maintenance organizations (HMOs) and pharmacy benefit managers, as well as various other institutional clients. Additionally, the company supplies products to individual physicians and their distributors, veterinarians, and livestock producers. The organization actively engages in strategic collaborations with companies such as AstraZeneca PLC, Bayer AG, Eisai Co., Ltd., Ridgeback Biotherapeutics, and Gilead Sciences, Inc. These partnerships are specifically aimed at the joint development and commercialization of prolonged-acting therapies for HIV. Established in 1891, Merck & Co., Inc. maintains its corporate headquarters in Kenilworth, New Jersey.
Prezzo delle azioni
$152.37
Capitalizzazione di mercato
$376.33B
Variazione (1 giorno)
12.46%
Variazione (1 anno)
79.41%
Paese
US
Scambia Merck & Co., Inc. (MRK)

Categoria

Ricavi di Merck & Co., Inc. (MRK)
Ricavi nel Jun 2026 TTM: $66.40B
Secondo gli ultimi rapporti finanziari di Merck & Co., Inc., i ricavi attuali dell'azienda (TTM) sono pari a $66.40B. Nel 2024, l'azienda ha registrato ricavi di $64.17B un aumento rispetto a i ricavi dell'anno 2023, che erano pari a $60.12B. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per Merck & Co., Inc. da 2000 a 2026
Ricavi alla fine di ogni anno
Anno Ricavi Cambia
2026 (TTM) $66.40B 2.14%
2025 $65.01B 1.31%
2024 $64.17B 6.74%
2023 $60.12B 1.40%
2022 $59.28B 21.72%
2021 $48.70B 17.31%
2020 $41.52B 6.13%
2019 $39.12B -7.50%
2018 $42.29B 5.41%
2017 $40.12B 0.79%
2016 $39.81B 0.78%
2015 $39.50B -6.48%
2014 $42.24B -4.08%
2013 $44.03B -6.84%
2012 $47.27B -1.62%
2011 $48.05B 4.48%
2010 $45.99B 67.66%
2009 $27.43B 15.00%
2008 $23.85B -1.44%
2007 $24.20B 6.90%
2006 $22.64B 2.84%
2005 $22.01B -4.18%
2004 $22.97B 2.17%
2003 $22.49B 4.85%
2002 $21.45B 1.16%
2001 $21.20B -47.48%
2000 $40.36B 0.00%
Ricavi di aziende simili o concorrenti
Azienda Ricavi Differenza nei ricavi Il paese
$79.67B 19.98%
US
$97.93B 47.48%
US
$64.39B -3.03%
US
$77.52B 16.74%
CH
$56.26B -15.27%
CH